Display options
Cite
Masago K, Fujita S. Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment. J Thorac Oncol. 2022;17(1):16-18doi: 10.1016/j.jtho.2021.10.002.
Masago, K., & Fujita, S. (2022). Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 17(1), 16-18. https://doi.org/10.1016/j.jtho.2021.10.002
Masago, Katsuhiro, and Fujita, Shiro. "Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 17,1 (2022): 16-18. doi: https://doi.org/10.1016/j.jtho.2021.10.002
Masago K, Fujita S. Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment. J Thorac Oncol. 2022 Jan;17(1):16-18. doi: 10.1016/j.jtho.2021.10.002. PMID: 34930606; PMCID: PMC8678031.
Copy Download .nbib Format: NLM
Share it on

J Thorac Oncol. 2022 Jan;17(1):16-18. doi: 10.1016/j.jtho.2021.10.002.

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Katsuhiro Masago, Shiro Fujita

Affiliations

  1. Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan. Electronic address: [email protected].
  2. Department of Respiratory Medicine, Kobe Central Hospital, Hyogo, Japan.

PMID: 34930606 PMCID: PMC8678031 DOI: 10.1016/j.jtho.2021.10.002

[No abstract available.]

References

  1. Cancer Discov. 2020 Dec;10(12):1842-1853 - PubMed
  2. Cancer Discov. 2017 Dec;7(12):1394-1403 - PubMed
  3. J Thorac Oncol. 2021 Oct;16(10):1647-1662 - PubMed
  4. Sci Transl Med. 2021 Aug 18;13(607): - PubMed
  5. Nat Commun. 2021 Aug 19;12(1):5045 - PubMed
  6. Biology (Basel). 2021 Jul 12;10(7): - PubMed
  7. J Thorac Oncol. 2022 Jan;17(1):154-159 - PubMed
  8. Swiss Med Wkly. 2021 Jul 20;151:w20557 - PubMed
  9. J Nucl Med. 2021 Jul 22;: - PubMed
  10. N Engl J Med. 2021 Jul 15;385(3):e11 - PubMed
  11. Int J Cancer. 2017 Sep 1;141(5):887-896 - PubMed
  12. Radiology. 2021 Jul;300(1):E296-E300 - PubMed
  13. Eur J Nucl Med. 1984;9(3):136-40 - PubMed
  14. Microbiol Rev. 1983 Dec;47(4):455-509 - PubMed
  15. MMWR Morb Mortal Wkly Rep. 2021 Jul 09;70(27):977-982 - PubMed
  16. GP. 1969 Jan;39(1):99-105 - PubMed
  17. AJR Am J Roentgenol. 2021 Oct;217(4):857-858 - PubMed
  18. N Engl J Med. 2021 Jun 3;384(22):2092-2101 - PubMed
  19. Ann Nucl Med. 2013 Nov;27(9):808-21 - PubMed
  20. mBio. 2021 Oct 26;12(5):e0190821 - PubMed
  21. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):321-331 - PubMed
  22. Ann Nucl Med. 2008 Jul;22(6):533-8 - PubMed
  23. Radiology. 2021 Aug;300(2):E323-E327 - PubMed
  24. Nucl Med Biol. 2020 Mar - Apr;82-83:9-16 - PubMed
  25. N Engl J Med. 2020 Dec 31;383(27):2603-2615 - PubMed
  26. Clin Microbiol Infect. 2014 Mar;20(3):210-8 - PubMed

Substances

MeSH terms

Publication Types